Cargando…
GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on co-expression network analysis
Gastric cancer is currently the fourth most common cancer and the third leading cause of cancer-associated mortality worldwide. Studies have identified that certain biomarkers contribute to the prognosis, diagnosis and treatment of gastric cancer. However, the biomarkers of gastric cancer are rarely...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278374/ https://www.ncbi.nlm.nih.gov/pubmed/30320360 http://dx.doi.org/10.3892/or.2018.6794 |